Profile | GDS4284 / 203680_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 388.228 | 60 |
GSM687648 | Patient 402 control | 828.451 | 71 |
GSM687653 | Patient 403 control | 270.759 | 55 |
GSM687658 | Patient 404 control | 1066.75 | 75 |
GSM687663 | Patient 411 control | 654.196 | 67 |
GSM687668 | Patient 422 control | 354.447 | 59 |
GSM687673 | Patient 424 control | 992.384 | 74 |
GSM687678 | Patient 425 control | 398.871 | 59 |
GSM687683 | Patient 427 control | 456.349 | 61 |
GSM687688 | Patient 428 control | 132.677 | 40 |
GSM687695 | Patient 441 control | 11467.8 | 97 |
GSM687699 | Patient 443 control | 470.158 | 61 |
GSM687704 | Patient 444 control | 382.509 | 60 |
GSM687707 | Patient 448 control | 1203.25 | 77 |
GSM687712 | Patient 449 control | 373.734 | 59 |
GSM687719 | Patient 450 control | 964.276 | 73 |
GSM687724 | Patient 451 control | 1529 | 81 |
GSM687728 | Patient 452 control | 2255.3 | 86 |
GSM687646 | Patient 401 treated 24h | 204.677 | 48 |
GSM687649 | Patient 402 treated 24h | 779.843 | 70 |
GSM687665 | Patient 411 treated 24h | 687.59 | 68 |
GSM687651 | Patient 402 treated 4 weeks | 697.923 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 408.418 | 60 |
GSM687670 | Patient 422 treated 24h | 382.101 | 59 |
GSM687671 | Patient 422 treated 4 weeks | 280.985 | 55 |
GSM687654 | Patient 403 treated 24h | 349.152 | 59 |
GSM687675 | Patient 424 treated 24h | 1237.29 | 77 |
GSM687685 | Patient 427 treated 24h | 263.103 | 53 |
GSM687656 | Patient 403 treated 4 weeks | 307.278 | 57 |
GSM687677 | Patient 424 treated 4 weeks | 265.705 | 53 |
GSM687687 | Patient 427 treated 4 weeks | 101.884 | 37 |
GSM687692 | Patient 428 treated 4h | 189.727 | 47 |
GSM687716 | Patient 449 treated 4h | 175.183 | 46 |
GSM687722 | Patient 450 treated 4h | 1333.37 | 78 |
GSM687680 | Patient 425 treated 24h | 531.356 | 64 |
GSM687690 | Patient 428 treated 24h | 242.099 | 53 |
GSM687700 | Patient 443 treated 24h | 1622.4 | 81 |
GSM687705 | Patient 444 treated 24h | 326.862 | 58 |
GSM687714 | Patient 449 treated 24h | 258.858 | 54 |
GSM687721 | Patient 450 treated 24h | 2102.01 | 85 |
GSM687682 | Patient 425 treated 4 weeks | 353.172 | 59 |
GSM687694 | Patient 428 treated 4 weeks | 267.719 | 55 |
GSM687702 | Patient 443 treated 4 weeks | 509.095 | 63 |
GSM687718 | Patient 449 treated 4 weeks | 106.471 | 35 |
GSM687723 | Patient 450 treated 4 weeks | 672.552 | 68 |
GSM687661 | Patient 404 treated 4h | 1029.9 | 74 |
GSM687710 | Patient 448 treated 4h | 1429.87 | 80 |
GSM687726 | Patient 451 treated 4h | 1535.34 | 80 |
GSM687730 | Patient 452 treated 4h | 679.393 | 64 |
GSM687660 | Patient 404 treated 24h | 5753.74 | 94 |
GSM687697 | Patient 441 treated 24h | 5669.46 | 94 |
GSM687709 | Patient 448 treated 24h | 1144.3 | 76 |
GSM687725 | Patient 451 treated 24h | 2491.29 | 87 |
GSM687729 | Patient 452 treated 24h | 9837.8 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 807.459 | 71 |
GSM687731 | Patient 452 treated 4 weeks | 2103.71 | 85 |